{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:01:31Z","timestamp":1789563691766,"version":"build-2803163510"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009706","name":"Erzincan Binali Yildirim University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010624","name":"Karabuk University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008770","name":"Anadolu University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008770","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.bioorg.2021.105009","type":"journal-article","created":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T11:38:17Z","timestamp":1621769897000},"page":"105009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"special_numbering":"C","title":["Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo[2,1-b][1,3,4]thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors"],"prefix":"10.1016","volume":"113","author":[{"given":"Sercan","family":"Askin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Tahtaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00fcneyt","family":"T\u00fcrke\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeliz","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulilah","family":"Ece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcl\u015fen","family":"Akal\u0131n \u00c7ift\u00e7i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015e\u00fckr\u00fc","family":"Beydemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.105009_b0005","first-page":"44","article-title":"Review on biological activities of 1,3,4-thiadiazole derivatives","volume":"1","author":"Arvind","year":"2011","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2021.105009_b0010","doi-asserted-by":"crossref","first-page":"11042","DOI":"10.1002\/slct.201802096","article-title":"Synthesis of new derivatives of 1, 2, 3-triazole-linked phthalazine-1, 4-dione in water: experimental aspects and molecular docking calculations","volume":"3","author":"Bakherad","year":"2018","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2021.105009_b0015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.carres.2019.05.003","article-title":"Synthesis and antiviral activity of some imidazo [1, 2-b][1, 3, 4] thiadiazole carbohydrate derivatives","volume":"480","author":"Fascio","year":"2019","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.bioorg.2021.105009_b0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1021\/cr60111a001","article-title":"Heterocyclic nitrogen compounds. Part IIA. Hexacyclic compounds: pyridine, quinoline, and isoquinoline","volume":"35","author":"Bergstrom","year":"1944","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2021.105009_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molstruc.2009.05.016","article-title":"The structure of N-allyl-(5-phenyl-[1, 3, 4] thiadiazol-2-yl) amine in solution and the solid state studied by the 1H, 13C, 15N NMR spectroscopy and X-ray crystallography","volume":"970","author":"Strzemecka","year":"2010","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2021.105009_b0030","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.tetlet.2015.02.027","article-title":"Reactions of 5-substituted 1, 3, 4-thiadiazole-2-thiones with chloroacetylenephosphonates","volume":"56","author":"Egorov","year":"2015","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2021.105009_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2020.130951","article-title":"Iodine-promoted direct thiolation (selenylation) of imidazole with disulfides (diselenide): A convenient and metal-free protocol for the synthesis of 2-arylthio (seleno) imidazole","volume":"76","author":"Yi","year":"2020","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2021.105009_b0040","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.bmc.2016.12.047","article-title":"Benzenesulfonamide bearing imidazothiadiazole and thiazolotriazole scaffolds as potent tumor associated human carbonic anhydrase IX and XII inhibitors","volume":"25","author":"Kumar","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0045","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0223-5234(00)00166-5","article-title":"Synthesis and antibacterial activity of some 5-guanylhydrazone\/thiocyanato-6-arylimidazo [2, 1-b]-1, 3, 4-thiadiazole-2-sulfonamide derivatives","volume":"35","author":"Gadad","year":"2000","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0050","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.3390\/molecules16075496","article-title":"Synthesis and antibacterial activities of novel imidazo [2, 1-b]-1, 3, 4-thiadiazoles","volume":"16","author":"Atta","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2021.105009_b0055","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejmech.2013.10.056","article-title":"Synthesis and biological evaluation of novel substituted 1, 3, 4-thiadiazole and 2, 6-di aryl substituted imidazo [2, 1-b][1, 3, 4] thiadiazole derivatives","volume":"71","author":"Chandrakantha","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0060","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ejmech.2015.03.021","article-title":"Novel imidazo [2, 1-b]-1, 3, 4-thiadiazoles as promising antifungal agents against clinical isolate of Cryptococcus neoformans","volume":"95","author":"Alwan","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0065","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5155\/eurjchem.2.1.94-99.161","article-title":"Synthesis, characterization and antimicrobial activity evaluation of new imidazo [2, 1-b][1, 3, 4] thiadiazole derivatives","volume":"2","author":"Alegaon","year":"2011","journal-title":"Eur. J. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejmech.2013.04.014","article-title":"Synthesis and antimicrobical evaluation of a novel class of\u00e11, 3, 4-thiadiazole: derivatives bearing 1, 2, 4-triazolo [1, 5-a] pyrimidine moiety","volume":"64","author":"Luo","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0075","first-page":"949","article-title":"Synthesis, anticonvulsant and analgesic activities of some 6-substituted imidazo (2, 1-b)-1, 3, 4-thiadiazole-2-sulfonamides and their 5-bromo derivatives","volume":"46","author":"Khazi","year":"1996","journal-title":"Arzneim.-Forsch."},{"key":"10.1016\/j.bioorg.2021.105009_b0080","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ejmech.2013.01.060","article-title":"Triazolothiadiazoles and triazolothiadiazines\u2013biologically attractive scaffolds","volume":"63","author":"Khan","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0085","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejmech.2015.03.024","article-title":"Synthesis and biological evaluation of new imidazo [2, 1-b][1, 3, 4] thiadiazole-benzimidazole derivatives","volume":"95","author":"Ramprasad","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104220","article-title":"Antioxidant activity of novel imidazo [2, 1-b] thiazole derivatives: design, synthesis, biological evaluation, molecular docking study and in silico ADME prediction","volume":"103","author":"Dincel","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0095","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejmech.2006.10.003","article-title":"Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted-1, 3, 4-oxadiazoles and 2-(1-adamantylamino)-5-substituted-1, 3, 4-thiadiazoles","volume":"42","author":"Kadi","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0100","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bmc.2007.09.038","article-title":"Synthesis and biological evaluation of 2-trifluoromethyl\/sulfonamido-5, 6-diaryl substituted imidazo [2, 1-b]-1, 3, 4-thiadiazoles: a novel class of cyclooxygenase-2 inhibitors","volume":"16","author":"Gadad","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0105","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejmech.2014.12.035","article-title":"1, 3, 4-Thiadiazoles: a potent multi targeted pharmacological scaffold","volume":"92","author":"Haider","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0110","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1021\/jm00400a003","article-title":"Antihypertensivethiadiazoles 1. Synthesis of some 2-aryl-5-hydrazino-1, 3, 4-thiadiazoles with vasodilator activity","volume":"31","author":"Turner","year":"1988","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0115","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1021\/jm00400a004","article-title":"Antihypertensive thiadiazoles. 2. Vasodilator activity of some 2-aryl-5-guanidino-1, 3, 4-thiadiazoles","volume":"31","author":"Turner","year":"1988","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0120","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejmech.2019.02.007","article-title":"2, 6-Disubstituted imidazo [2, 1-b][1, 3, 4] thiadiazole derivatives as potent staphylococcal biofilm inhibitors","volume":"167","author":"Cascioferro","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0125","first-page":"550","article-title":"Synthesis and antisecretory activity of 6-substituted 5-cyanomethylimidazo [2, 1-b]-thiazoles and 2, 6-dimethyl-5-hydroxymethylimidazo [2, 1-b][1, 3, 4] thiadiazole","volume":"50","author":"Andreani","year":"2000","journal-title":"Prog. Drug Res."},{"key":"10.1016\/j.bioorg.2021.105009_b0130","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1016\/j.bmc.2004.07.060","article-title":"Synthesis and anti-tubercular activity of a series of 2-sulfonamido\/trifluoromethyl-6-substituted imidazo [2, 1-b]-1, 3, 4-thiadiazole derivatives","volume":"12","author":"Gadad","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0135","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/17415990600987957","article-title":"Mannich bases and novel benzothiazole derivatives of imidazo [2, 1-b][1, 3, 4] thiadiazoles and their biological evaluation","volume":"27","author":"Hegde","year":"2006","journal-title":"J. Sulfur Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0140","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.bmcl.2012.01.052","article-title":"Novel imidazo [2, 1-b][1, 3, 4] thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents","volume":"22","author":"Alegaon","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.105009_b0145","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1039\/b923882d","article-title":"Synthesis and biological evaluation of a triazole-based library of pyrido [2, 3-d] pyrimidines as FGFR3 tyrosine kinase inhibitors","volume":"8","author":"Le Corre","year":"2010","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2015.07.010","article-title":"A historical overview of protein kinases and their targeted small molecule inhibitors","volume":"100","author":"Roskoski","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2021.105009_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128657","article-title":"Synthesis, characterization and biological activity evaluation of novel naphthalenylmethylen hydrazine derivatives as carbonic anhydrase inhibitors","volume":"1220","author":"Shirinzadeh","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2021.105009_b0160","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1080\/00958972.2017.1366996","article-title":"Synthesis, crystal structure, spectroscopy, thermal properties and carbonic anhydrase activities of new metal (II) complexes with mefenamic acid and picoline derivatives","volume":"70","author":"Dilek","year":"2017","journal-title":"J. Coord. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0165","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.12956","article-title":"Carbonic anhydrase, obstructive sleep apnea and hypertension: effects of intervention","volume":"29","author":"Hoff","year":"2020","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.bioorg.2021.105009_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103134","article-title":"Novel 2-aminopyridine liganded Pd (II) N-heterocyclic carbene complexes: synthesis, characterization, crystal structure and bioactivity properties","volume":"91","author":"Erdemir","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0175","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1080\/01480545.2018.1463242","article-title":"The behavior of some chalcones on acetylcholinesterase and carbonic anhydrase activity","volume":"42","author":"Aslan","year":"2019","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.bioorg.2021.105009_b0180","doi-asserted-by":"crossref","first-page":"e2000375","DOI":"10.1002\/ardp.202000375","article-title":"Synthesis and in vitro carbonic anhydrases and acetylcholinesterase inhibitory activities of novel imidazolinone\u2010based benzenesulfonamides","volume":"354","author":"Tugrak","year":"2020","journal-title":"Arch. Pharm. (Weinheim, Ger.)"},{"key":"10.1016\/j.bioorg.2021.105009_b0185","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1111\/jog.14506","article-title":"Relationship between zinc content and carbonic anhydrase activity in blood of anemic pregnant women in Turkey","volume":"46","author":"G\u00f6ktu\u011f Kad\u0131o\u011flu","year":"2020","journal-title":"J. Obstetrics Gynaecology Res."},{"key":"10.1016\/j.bioorg.2021.105009_b0190","first-page":"1183","article-title":"Protein misfolding and aggregation: mechanism, factors and detection","volume":"51","author":"Chaturvedi","year":"2016","journal-title":"Process Biochem. (Amsterdam, Neth.)"},{"key":"10.1016\/j.bioorg.2021.105009_b0195","first-page":"73","article-title":"Molecular genetics of Alzheimer's Disease","volume":"6","author":"Yoke\u015f","year":"2007","journal-title":"J. Cell Mol. Biol."},{"key":"10.1016\/j.bioorg.2021.105009_b0200","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ijbiomac.2018.12.271","article-title":"Molecular docking of A\u03b21\u201340 peptide and its Iowa D23N mutant using small molecule inhibitors: possible mechanisms of A\u03b2-peptide inhibition","volume":"127","author":"Khan","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2021.105009_b0205","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s11011-018-0221-7","article-title":"Tacrine (10)-hupyridone, a dual-binding acetylcholinesterase inhibitor, potently attenuates scopolamine-induced impairments of cognition in mice","volume":"33","author":"Chen","year":"2018","journal-title":"Metab. Brain Disease"},{"key":"10.1016\/j.bioorg.2021.105009_b0210","doi-asserted-by":"crossref","first-page":"9675","DOI":"10.1002\/chem.201801394","article-title":"Potent 3-hydroxy-2-pyridine aldoxime reactivators of organophosphate-inhibited cholinesterases with predicted blood-brain barrier penetration","volume":"24","author":"Zorbaz","year":"2018","journal-title":"Chem. - Eur. J."},{"key":"10.1016\/j.bioorg.2021.105009_b0215","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1002\/chem.201805051","article-title":"Reversal of tabun toxicity enabled by a triazole-annulated oxime library\u2014Reactivators of acetylcholinesterase","volume":"25","author":"Kovarik","year":"2019","journal-title":"Chem. - Eur. J."},{"key":"10.1016\/j.bioorg.2021.105009_b0220","doi-asserted-by":"crossref","first-page":"e2000958","DOI":"10.1002\/cbdv.202000958","article-title":"Synthesis, characterization, and inhibition study of novel substituted phenylureido sulfaguanidine derivatives as \u03b1-glycosidase and cholinesterase inhibitors","volume":"18","author":"Akocak","year":"2021","journal-title":"Chem. Biodiversity"},{"key":"10.1016\/j.bioorg.2021.105009_b0225","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bioorg.2018.08.003","article-title":"Novel thymol bearing oxypropanolamine derivatives as potent some metabolic enzyme inhibitors\u2013Their antidiabetic, anticholinergic and antibacterial potentials","volume":"81","author":"Zengin","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0230","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1212\/WNL.40.8.1225","article-title":"Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations","volume":"40","author":"Salmon","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.bioorg.2021.105009_b0235","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1021\/jm0495632","article-title":"1, 3, 4-thiadiazole derivatives. Synthesis, structure elucidation, and structure\u2212 antituberculosis activity relationship investigation","volume":"47","author":"Oru\u00e7","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0240","first-page":"617","article-title":"Synthesis of 3-(3, 4-dimethoxyphenyl)-1 H-1, 2, 4-triazole-5-thiol and 2-amino-5-(3, 4-dimethoxyphenyl)-1, 3, 4-thiadiazole derivatives exhibiting anti-inflammatory activity","volume":"56","author":"Labanauskas","year":"2001","journal-title":"Die Pharm."},{"key":"10.1016\/j.bioorg.2021.105009_b0245","doi-asserted-by":"crossref","first-page":"S463","DOI":"10.1016\/j.jscs.2013.01.010","article-title":"Biological activities of imidazo [2, 1-b][1, 3, 4] thiadiazole derivatives: a review","volume":"20","author":"Bhongade","year":"2016","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.bioorg.2021.105009_b0250","doi-asserted-by":"crossref","first-page":"S996","DOI":"10.1016\/j.arabjc.2013.01.001","article-title":"Synthesis and antitubercular evaluation of imidazo [2, 1-b][1, 3, 4] thiadiazole derivatives","volume":"10","author":"Patel","year":"2017","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0255","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2174\/1570180816666181108115510","article-title":"Synthesis and in vitro biological activity evaluation of novel imidazo [2, 1-B][1, 3, 4] thiadiazole as anti-alzheimer agents","volume":"17","author":"Azimi","year":"2020","journal-title":"Lett. Drug Des. Discovery"},{"key":"10.1016\/j.bioorg.2021.105009_b0260","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1080\/00397911.2020.1797814","article-title":"Design, synthesis, and biological evaluation of amide derivatives of imidazo [2, 1-b][1, 3, 4] thiadiazole as anticancer agents","volume":"50","author":"Sridhar","year":"2020","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bioorg.2021.105009_b0265","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100028","article-title":"Design and synthesis of benzenesulfonamide\u2010linked imidazo [2, 1\u2010b][1, 3, 4] thiadiazole derivatives as carbonic anhydrase I and II inhibitors","author":"Swain","year":"2021","journal-title":"Arch. Pharm. (Weinheim, Ger.)"},{"key":"10.1016\/j.bioorg.2021.105009_b0270","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.molstruc.2016.01.045","article-title":"Novel 2-amino-1, 3, 4-thiadiazoles and their acyl derivatives: Synthesis, structural characterization, molecular docking studies and comparison of experimental and computational results","volume":"1110","author":"Er","year":"2016","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2021.105009_b0275","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13065-018-0485-3","article-title":"An integrated approach towards the development of novel antifungal agents containing thiadiazole: synthesis and a combined similarity search, homology modelling, molecular dynamics and molecular docking study","volume":"12","author":"Er","year":"2018","journal-title":"Chem. Central J."},{"key":"10.1016\/j.bioorg.2021.105009_b0280","doi-asserted-by":"crossref","first-page":"14281","DOI":"10.1002\/slct.201903886","article-title":"A novel class substituted imidazo [2, 1-b][1, 3, 4] thiadiazole derivatives: synthesis, characterization, in vitro biological activity, and potential inhibitors design studies","volume":"4","author":"Er","year":"2019","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2021.105009_b0285","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00044-017-1782-4","article-title":"Synthesis, characterization, preliminary SAR and molecular docking study of some novel substituted imidazo [2, 1-b][1, 3, 4] thiadiazole derivatives as antifungal agents","volume":"26","author":"Er","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2021.105009_b0290","doi-asserted-by":"crossref","first-page":"1700083","DOI":"10.1002\/minf.201700083","article-title":"Design, synthesis, SAR and molecular modeling studies of novel imidazo [2, 1-b][1, 3, 4] thiadiazole derivatives as highly potent antimicrobial agents","volume":"37","author":"Tahtaci","year":"2018","journal-title":"Mol. Informatics"},{"key":"10.1016\/j.bioorg.2021.105009_b0295","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.molstruc.2019.05.104","article-title":"Novel substituted benzothiazole and Imidazo [2, 1-b][1, 3, 4] Thiadiazole derivatives: synthesis, characterization, molecular docking study, and investigation of their in vitro antileishmanial and antibacterial activities","volume":"1194","author":"Er","year":"2019","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2021.105009_b0300","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1016\/j.bmc.2005.12.020","article-title":"Synthesis and evaluation of antitubercular activity of imidazo [2, 1-b][1, 3, 4] thiadiazole derivatives","volume":"14","author":"Kolavi","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0305","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejmech.2013.04.020","article-title":"2, 5, 6-Trisubstituted imidazo [2, 1-b][1, 3, 4] thiadiazoles: Search for antihyperlipidemic agents","volume":"65","author":"Patel","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0310","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3390\/md15120366","article-title":"Computer-aided drug design applied to marine drug discovery: meridianins as Alzheimer\u2019s disease therapeutic agents","volume":"15","author":"Llorach-Pares","year":"2017","journal-title":"Marine Drugs"},{"key":"10.1016\/j.bioorg.2021.105009_b0315","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.sbi.2017.10.010","article-title":"Protein structure-based drug design: from docking to molecular dynamics","volume":"48","author":"\u015aled\u017a","year":"2018","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.bioorg.2021.105009_b0320","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/07391102.2019.1583606","article-title":"Towards more effective acetylcholinesterase inhibitors: a comprehensive modelling study based on human acetylcholinesterase protein\u2013drug complex","volume":"38","author":"Ece","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2021.105009_b0325","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3109\/14756366.2014.949256","article-title":"A computational insight into acetylcholinesterase inhibitory activity of a new lichen depsidone","volume":"30","author":"Ece","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0330","doi-asserted-by":"crossref","DOI":"10.1111\/jphp.13269","article-title":"Bioactive indanes: insight into the bioactivity of indane dimers related to the lead anti-inflammatory molecule PH46A","author":"Chan","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bioorg.2021.105009_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.csbj.2020.06.016","article-title":"Exploring the structural basis of conformational heterogeneity and autoinhibition of human cGMP-specific Protein Kinase I\u03b1 through computational modelling and molecular dynamics simulations","author":"Maryam","year":"2020","journal-title":"Comput. Struct. Biotech. J."},{"key":"10.1016\/j.bioorg.2021.105009_b0340","first-page":"1","article-title":"Novel inhibitors with sulfamethazine backbone: Synthesis and biological study of multi-target cholinesterases and \u03b1-glucosidase inhibitors","author":"T\u00fcrke\u015f","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2021.105009_b0345","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1021\/jm1013242","article-title":"Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases","volume":"54","author":"Davis","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0350","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/cbdd.13149","article-title":"Synthesis, molecular modeling, and biological evaluation of 4-[5-aryl-3-(thiophen-2-yl)-4, 5-dihydro-1H-pyrazol-1-yl] benzenesulfonamides toward acetylcholinesterase, carbonic anhydrase I and II enzymes","volume":"91","author":"Yamali","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2021.105009_b0355","doi-asserted-by":"crossref","first-page":"13347","DOI":"10.1002\/slct.201903458","article-title":"New isoindole-1, 3-dione substituted sulfonamides as potent inhibitors of carbonic anhydrase and acetylcholinesterase: design, synthesis, and biological evaluation","volume":"4","author":"G\u00fcndo\u011fdu","year":"2019","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2021.105009_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103004","article-title":"Synthesis, biological evaluation and in silico studies of novel N-substituted phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors","volume":"89","author":"T\u00fcrke\u015f","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103222","article-title":"Synthesis, biological evaluation and in silico modelling studies of 1, 3, 5-trisubstituted pyrazoles carrying benzenesulfonamide as potential anticancer agents and selective cancer-associated hCA IX isoenzyme inhibitors","volume":"92","author":"Yamali","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0370","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1080\/14756366.2020.1746784","article-title":"Synthesis, characterization, biological evaluation and in silico studies of sulfonamide Schiff bases","volume":"35","author":"Durgun","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0375","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1080\/07391102.2020.1736631","article-title":"Calcium channel blockers: molecular docking and inhibition studies on carbonic anhydrase I and II isoenzymes","volume":"39","author":"T\u00fcrke\u015f","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2021.105009_b0380","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s00044-018-2226-5","article-title":"Isoindolines\/isoindoline-1, 3-diones as AChE inhibitors against Alzheimer\u2019s disease, evaluated by an improved ultra-micro assay","volume":"27","author":"Andrade-Jorge","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2021.105009_b0385","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.3390\/md12042114","article-title":"Insights and ideas garnered from marine metabolites for development of dual-function acetylcholinesterase and amyloid-\u03b2 aggregation inhibitors","volume":"12","author":"Stoddard","year":"2014","journal-title":"Marine Drugs"},{"key":"10.1016\/j.bioorg.2021.105009_b0390","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1080\/07391102.2018.1465853","article-title":"Novel coumarin derivatives as potent acetylcholinesterase inhibitors: insight into efficacy, mode and site of inhibition","volume":"37","author":"Baruah","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2021.105009_b0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijbiomac.2020.12.121","article-title":"Design, synthesis, characterization, enzymatic inhibition evaluations, and docking study of novel quinazolinone derivatives","volume":"170","author":"Pedrood","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2021.105009_b0400","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/S0021-9258(18)95800-X","article-title":"Esterase activities of human carbonic anhydrases B and C","volume":"242","author":"Verpoorte","year":"1967","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0405","doi-asserted-by":"crossref","first-page":"e2000102","DOI":"10.1002\/ardp.202000102","article-title":"Synthesis, characterization, biological evaluation, and in silico studies of novel 1, 3\u2010diaryltriazene\u2010substituted sulfathiazole derivatives","volume":"353","author":"I\u015f\u0131k","year":"2020","journal-title":"Arch. Pharm. (Weinheim, Ger.)"},{"key":"10.1016\/j.bioorg.2021.105009_b0410","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.ijbiomac.2020.09.043","article-title":"Thiazolyl-pyrazoline derivatives: in vitro and in silico evaluation as potential acetylcholinesterase and carbonic anhydrase inhibitors","volume":"163","author":"Sever","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2021.105009_b0415","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2021.105009_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103897","article-title":"Synthesis, characterization, inhibition effects, and molecular docking studies as acetylcholinesterase, \u03b1-glycosidase, and carbonic anhydrase inhibitors of novel benzenesulfonamides incorporating 1, 3, 5-triazine structural motifs","volume":"100","author":"Lolak","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.jorganchem.2020.121542","article-title":"Mannich reaction derived novel boron complexes with amine-bis (phenolate) ligands: Synthesis, spectroscopy and in vitro\/in silico biological studies","volume":"927","author":"Kilic","year":"2020","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0430","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/jphp.13144","article-title":"The behaviour of some antihypertension drugs on human serum paraoxonase-1: an important protector enzyme against atherosclerosis","volume":"71","author":"Demir","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bioorg.2021.105009_b0435","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1021\/bi201284u","article-title":"The original Michaelis constant: translation of the 1913 Michaelis-Menten paper","volume":"50","author":"Johnson","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2021.105009_b0440","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/ja01318a036","article-title":"The determination of enzyme dissociation constants","volume":"56","author":"Lineweaver","year":"1934","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2021.105009_b0445","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3109\/14756366.2012.715287","article-title":"Synthesis and paroxonase activities of novel bromophenols","volume":"28","author":"Akbaba","year":"2013","journal-title":"J. Enzyme Inhibit. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0450","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pharep.2013.08.007","article-title":"Effect of calcium channel blockers on paraoxonase-1 (PON1) activity and oxidative stress","volume":"66","author":"T\u00fcrke\u015f","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bioorg.2021.105009_b0455","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/ddr.21667","article-title":"Naphthoquinones, benzoquinones, and anthraquinones: molecular docking, ADME and inhibition studies on human serum paraoxonase-1 associated with cardiovascular diseases","volume":"81","author":"Demir","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2021.105009_b0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2020.1763838","article-title":"Benzenesulfonamide derivatives as potent acetylcholinesterase, \u03b1-glycosidase, and glutathione S-transferase inhibitors: biological evaluation and molecular docking studies","author":"Taslimi","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2021.105009_b0465","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1515\/chem-2021-0032","article-title":"A new series of 2,4-thiazolidinediones endowed with potent aldose reductase inhibitory activity","volume":"19","author":"Sever","year":"2021","journal-title":"Open Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0470","doi-asserted-by":"crossref","first-page":"e1900383","DOI":"10.1002\/ardp.201900383","article-title":"Sulfonamides incorporating ketene N,S-acetal bioisosteres as potent carbonic anhydrase and acetylcholinesterase inhibitors","volume":"353","author":"Istrefi","year":"2020","journal-title":"Arch. Pharm. (Weinheim, Ger.)"},{"key":"10.1016\/j.bioorg.2021.105009_b0475","doi-asserted-by":"crossref","first-page":"e2000282","DOI":"10.1002\/ardp.202000282","article-title":"Novel benzoic acid derivatives: Synthesis and biological evaluation as multi-target acetylcholinesterase and carbonic anhydrase inhibitors","volume":"354","author":"Kalayc\u0131","year":"2021","journal-title":"Arch. Pharm. (Weinheim, Ger.)"},{"key":"10.1016\/j.bioorg.2021.105009_b0480","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3109\/14756366.2014.959511","article-title":"Human serum paraoxonase-1 (hPON1): in vitro inhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium","volume":"30","author":"T\u00fcrke\u015f","year":"2015","journal-title":"J. Enzyme Inhibit. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0485","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.etap.2015.11.024","article-title":"In vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serum","volume":"42","author":"T\u00fcrke\u015f","year":"2016","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.bioorg.2021.105009_b0490","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s12010-019-03009-x","article-title":"Anti-diabetic properties of calcium channel blockers: inhibition effects on aldose reductase enzyme activity","volume":"189","author":"T\u00fcrke\u015f","year":"2019","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.bioorg.2021.105009_b0495","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12010-019-03073-3","article-title":"Inhibition of human serum paraoxonase-I with antimycotic drugs: in vitro and in silico studies","volume":"190","author":"T\u00fcrke\u015f","year":"2020","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.bioorg.2021.105009_b0500","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2021.105009_b0505","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejmech.2016.09.035","article-title":"Synthesis and evaluation of new benzodioxole-based dithiocarbamate derivatives as potential anticancer agents and hCA-I and hCA-II inhibitors","volume":"125","author":"Alt\u0131ntop","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0510","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.ejmech.2018.06.049","article-title":"Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors","volume":"155","author":"Alt\u0131ntop","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0515","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2174\/1871520620666200218110645","article-title":"Molecular docking studies and inhibition properties of some antineoplastic agents against paraoxonase-I","volume":"20","author":"Demir","year":"2020","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0520","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2174\/0929866526666190226162225","article-title":"Investigation of potential paraoxonase-I inhibitors by kinetic and molecular docking studies: chemotherapeutic drugs","volume":"26","author":"T\u00fcrke\u015f","year":"2019","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.bioorg.2021.105009_b0525","first-page":"1","article-title":"Gadolinium-based contrast agents: in vitro paraoxonase 1 inhibition, in silico studies","author":"Beydemir","year":"2019","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.bioorg.2021.105009_b0530","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/jphp.13141","article-title":"A potential risk factor for paraoxonase 1: in silico and in-vitro analysis of the biological activity of proton-pump inhibitors","volume":"71","author":"T\u00fcrke\u015f","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bioorg.2021.105009_b0535","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s11696-019-00988-3","article-title":"Molecular docking and investigation of 4-(benzylideneamino)-and 4-(benzylamino)-benzenesulfonamide derivatives as potent AChE inhibitors","volume":"74","author":"I\u015f\u0131k","year":"2020","journal-title":"Chem. Pap."},{"key":"10.1016\/j.bioorg.2021.105009_b0540","unstructured":"Schr\u00f6dinger, LigPrep, in, Schr\u00f6dinger, LLC, New York, NY, 2020."},{"key":"10.1016\/j.bioorg.2021.105009_b0545","unstructured":"Schr\u00f6dinger, Small-Molecule Drug Discovery Suite, in, Schr\u00f6dinger, LLC, New York, NY, 2020."},{"key":"10.1016\/j.bioorg.2021.105009_b0550","first-page":"1","article-title":"Some calcium-channel blockers: kinetic and in silico studies on paraoxonase-I","author":"T\u00fcrke\u015f","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2021.105009_b0555","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bioorg.2021.105009_b0560","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1021\/ja068359w","article-title":"Structural analysis of charge discrimination in the binding of inhibitors to human carbonic anhydrases I and II","volume":"129","author":"Srivastava","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2021.105009_b0565","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1107\/S1744309109036665","article-title":"High-resolution structure of human carbonic anhydrase II complexed with acetazolamide reveals insights into inhibitor drug design","volume":"65","author":"Sippel","year":"2009","journal-title":"Acta Crystallogr. Sect. F: Struct. Biol. Cryst. Commun."},{"key":"10.1016\/j.bioorg.2021.105009_b0570","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0014-5793(99)01637-3","article-title":"Structure of acetylcholinesterase complexed with (\u2212)-galanthamine at 2.3 \u00c5 resolution","volume":"463","author":"Greenblatt","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bioorg.2021.105009_b0575","doi-asserted-by":"crossref","first-page":"9731","DOI":"10.1002\/slct.201902424","article-title":"In vitro and in silico studies on the toxic effects of antibacterial drugs as human serum paraoxonase 1 inhibitor","volume":"4","author":"T\u00fcrke\u015f","year":"2019","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2021.105009_b0580","unstructured":"Schr\u00f6dinger, Protein Preparation Wizard, in, Schr\u00f6dinger, LLC, New York, NY, 2020."},{"key":"10.1016\/j.bioorg.2021.105009_b0585","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput.-Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2021.105009_b0590","unstructured":"Schr\u00f6dinger, Receptor Grid Generation, in, Schr\u00f6dinger, LLC, New York, NY, 2020."},{"key":"10.1016\/j.bioorg.2021.105009_b0595","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.ijbiomac.2019.09.237","article-title":"Benzenesulfonamide derivatives containing imine and amine groups: Inhibition on human paraoxonase and molecular docking studies","volume":"146","author":"I\u015f\u0131k","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2021.105009_b0600","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0605","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105009_b0610","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821003862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821003862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:18:11Z","timestamp":1758615491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821003862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":122,"alternative-id":["S0045206821003862"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105009","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo[2,1-b][1,3,4]thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105009"}}